Jonathan Corren
4PUBLICATIONS
14CO-AUTHORS
Get your video featured.
Publish with JoVEGet your video featured.
Publish with JoVE
Publications (4)
Sort by Publication Date:
|Mar 25, 2024
Tezepelumab for Severe Asthma: One Drug Targeting Multiple Disease Pathways and Patient Types.Reynold Panettieri, Njira Lugogo, Jonathan Corren
|Sep 26, 2023
Efficacy of dupilumab in patients with uncontrolled, moderate-to-severe asthma with fungal sensitization.Jonathan Corren, Nicola A Hanania, William W Busse
|Jul 11, 2023
Dupilumab sustains efficacy in patients with moderate-to-severe type 2 asthma regardless of inhaled corticosteroids dose.Ian D Pavord, Arnaud Bourdin, Alberto Papi
|Dec 12, 2022
Efficacy of tezepelumab in patients with evidence of severe allergic asthma: Results from the phase 3 NAVIGATOR study.Jonathan Corren, Christopher S Ambrose, Janet M Griffiths
Pageof 1
Frequent Collaborators
1 joint publications
Jean-Pierre Llanos
1 joint publications
Ian D Pavord
1 joint publications
Arnaud Bourdin
1 joint publications
Alberto Papi
1 joint publications
Christian Domingo
1 joint publications
Arman Altincatal
1 joint publications
Amr Radwan
1 joint publications
Nami Pandit-Abid
1 joint publications
Juby A Jacob-Nara
1 joint publications
David J Lederer
